Isorhamnetin inhibits progression of ovarian cancer by targeting ESR1
- Reference:
- Annals of Translational Medicine
- 2022
- 10
- 1216
- DOI:
- 10.21037/atm-22-5064
Here we provide a literature database for flavonoids, focused upon quercetin, rutin, isorhamnetin, and their related compounds. Original papers and reviews about in vitro, in vivo, and clinical pharmacologies are contained here.